Opsonic Phagocytosis of Plasmodium Falciparum Merozoites: Mechanism in Human Immunity and a Correlate of Protection Against Malaria

Overview

Journal BMC Med

Publisher Biomed Central

Specialty General Medicine

Date 2014 Jul 2

PMID 24980799

Citations 149

Authors

Faith Ha Osier

Gaoqian Feng

Michelle J Boyle

Christine Langer

Jingling Zhou

Jack S Richards

Fiona J McCallum

Linda Reiling

Anthony Jaworowski

Robin F Anders

Kevin Marsh

James G Beeson

Affiliations

Soon will be listed here.

Abstract

Background: An understanding of the mechanisms mediating protective immunity against malaria in humans is currently lacking, but critically important to advance the development of highly efficacious vaccines. Antibodies play a key role in acquired immunity, but the functional basis for their protective effect remains unclear. Furthermore, there is a strong need for immune correlates of protection against malaria to guide vaccine development.

Methods: Using a validated assay to measure opsonic phagocytosis of Plasmodium falciparum merozoites, we investigated the potential role of this functional activity in human immunity against clinical episodes of malaria in two independent cohorts (n = 109 and n = 287) experiencing differing levels of malaria transmission and evaluated its potential as a correlate of protection.

Results: Antibodies promoting opsonic phagocytosis of merozoites were cytophilic immunoglobulins (IgG1 and IgG3), induced monocyte activation and production of pro-inflammatory cytokines, and were directed against major merozoite surface proteins (MSPs). Consistent with protective immunity in humans, opsonizing antibodies were acquired with increasing age and malaria exposure, were boosted on re-infection, and levels were related to malaria transmission intensity. Opsonic phagocytosis was strongly associated with a reduced risk of clinical malaria in longitudinal studies in children with current or recent infections. In contrast, antibodies to the merozoite surface in standard immunoassays, or growth-inhibitory antibodies, were not significantly associated with protection. In multivariate analyses including several antibody responses, opsonic phagocytosis remained significantly associated with protection against malaria, highlighting its potential as a correlate of immunity. Furthermore, we demonstrate that human antibodies against MSP2 and MSP3 that are strongly associated with protection in this population are effective in opsonic phagocytosis of merozoites, providing a functional link between these antigen-specific responses and protection for the first time.

Conclusions: Opsonic phagocytosis of merozoites appears to be an important mechanism contributing to protective immunity in humans. The opsonic phagocytosis assay appears to be a strong correlate of protection against malaria, a valuable biomarker of immunity, and provides a much-needed new tool for assessing responses to blood-stage malaria vaccines and measuring immunity in populations.

Citing Articles

A multivalent binding model infers antibody Fc species from systems serology.

Abraham A, Tan Z, Shrestha P, Bozich E, Meyer A PLoS Comput Biol. 2024; 20(12):e1012663.

PMID: 39715286 PMC: 11706497. DOI: 10.1371/journal.pcbi.1012663.

Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection.

Mukhiya R, Fleischmann W, Loughland J, Chan J, De Labastida Rivera F, Andrew D EBioMedicine. 2024; 109:105419.

PMID: 39490199 PMC: 11576503. DOI: 10.1016/j.ebiom.2024.105419.

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.

Wang L, Cooper A, Farrell B, Miura K, Diouf A, Muller-Sienerth N Cell. 2024; 187(18):4981-4995.e14.

PMID: 39059381 PMC: 11383431. DOI: 10.1016/j.cell.2024.06.037.

How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays.

Miura K Vaccines (Basel). 2024; 12(6).

PMID: 38932315 PMC: 11209467. DOI: 10.3390/vaccines12060586.

The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.

Boyle M, Engwerda C, Jagannathan P Nat Rev Immunol. 2024; 24(9):637-653.

PMID: 38862638 PMC: 11688169. DOI: 10.1038/s41577-024-01041-5.

References

Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P . Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med. 1995; 182(2):409-18. PMC: 2192140. DOI: 10.1084/jem.182.2.409. View

Stubbs J, Olugbile S, Saidou B, Simpore J, Corradin G, Lanzavecchia A . Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies. Infect Immun. 2010; 79(3):1143-52. PMC: 3067485. DOI: 10.1128/IAI.01034-10. View

Agak G, Bejon P, Fegan G, Gicheru N, Villard V, Kajava A . Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. Vaccine. 2008; 26(16):1963-71. DOI: 10.1016/j.vaccine.2008.02.020. View

Hill D, Eriksson E, Li Wai Suen C, Chiu C, Ryg-Cornejo V, Robinson L . Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria. PLoS One. 2013; 8(9):e74627. PMC: 3767630. DOI: 10.1371/journal.pone.0074627. View

Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P . Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991; 45(3):297-308. DOI: 10.4269/ajtmh.1991.45.297. View

Murray P, Wynn T . Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11(11):723-37. PMC: 3422549. DOI: 10.1038/nri3073. View

Jafarshad A, Dziegiel M, Lundquist R, Nielsen L, Singh S, Druilhe P . A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol. 2007; 178(5):3099-106. DOI: 10.4049/jimmunol.178.5.3099. View

Khusmith S, Druilhe P . Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect Immun. 1983; 41(1):219-23. PMC: 264766. DOI: 10.1128/iai.41.1.219-223.1983. View

Hill D, Eriksson E, Carmagnac A, Wilson D, Cowman A, Hansen D . Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites. PLoS One. 2013; 7(12):e51692. PMC: 3530572. DOI: 10.1371/journal.pone.0051692. View

10.

Boyle M, Wilson D, Richards J, Riglar D, Tetteh K, Conway D . Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc Natl Acad Sci U S A. 2010; 107(32):14378-83. PMC: 2922570. DOI: 10.1073/pnas.1009198107. View

11.

Druilhe P, Spertini F, Soesoe D, Corradin G, Mejia P, Singh S . A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum. PLoS Med. 2005; 2(11):e344. PMC: 1277929. DOI: 10.1371/journal.pmed.0020344. View

12.

Marsh K, Otoo L, Hayes R, Carson D, Greenwood B . Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg. 1989; 83(3):293-303. DOI: 10.1016/0035-9203(89)90478-1. View

13.

McCarthy J, Marjason J, Elliott S, Fahey P, Bang G, Malkin E . A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720. PLoS One. 2011; 6(9):e24413. PMC: 3176224. DOI: 10.1371/journal.pone.0024413. View

14.

Beeson J, Osier F, Engwerda C . Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol. 2008; 24(12):578-84. DOI: 10.1016/j.pt.2008.08.008. View

15.

Marzio R, Jirillo E, Ransijn A, Mauel J, Corradin S . Expression and function of the early activation antigen CD69 in murine macrophages. J Leukoc Biol. 1997; 62(3):349-55. DOI: 10.1002/jlb.62.3.349. View

16.

Mbogo C, Snow R, Kabiru E, Ouma J, Githure J, Marsh K . Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. Am J Trop Med Hyg. 1993; 49(2):245-53. DOI: 10.4269/ajtmh.1993.49.245. View

17.

Adda C, MacRaild C, Reiling L, Wycherley K, Boyle M, Kienzle V . Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2. Infect Immun. 2012; 80(12):4177-85. PMC: 3497424. DOI: 10.1128/IAI.00665-12. View

18.

Joos C, Marrama L, Polson H, Corre S, Diatta A, Diouf B . Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One. 2010; 5(3):e9871. PMC: 2845614. DOI: 10.1371/journal.pone.0009871. View

19.

Lund P, Joo G, Westvik A, Ovstebo R, Kierulf P . Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest. 2000; 60(5):357-65. DOI: 10.1080/003655100750019260. View

20.

Beeson J, Brown G, Molyneux M, Mhango C, Dzinjalamala F, Rogerson S . Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis. 1999; 180(2):464-72. PMC: 2613477. DOI: 10.1086/314899. View